Nojine Achieves 100% Pharmacopoeial Compliance Under WHO-GMP Biological Standards

Following a rigorous multi-week audit conducted by national regulatory bodies and international quality inspectors, Nojine Zist Pharmed achieved a flawless 100% compliance rating in accordance with WHO Good Manufacturing Practice (GMP) guidelines for biological medicinal products.

The inspection covered all critical infrastructure subsystems: cleanroom differential pressure monitoring, high-efficiency particulate air (HEPA) filtration integrity, continuous environmental telemetry, water-for-injection (WFI) loop sterility, and computerized batch tracking mechanisms.

‘Attaining zero critical or major observations across our bioprocessing units reflects our unyielding commitment to patient safety and quality by design (QbD),’ stated the Director of Quality Assurance at Nojine Zist Pharmed.